Turk Ilac ve Serum Sanayi AS

IS:TRILC Turkey Drug Manufacturers - Specialty & Generic
Market Cap
$72.37 Million
TL2.57 Billion TRY
Market Cap Rank
#22951 Global
#310 in Turkey
Share Price
TL15.86
Change (1 day)
+0.89%
52-Week Range
TL15.01 - TL25.26
All Time High
TL37.80
About

Turk Ilac Ve Serum Sanayi Anonim Sirketi produces and sells human tablets, parenteral solutions, nutritional solutions, amino acids, and other chemicals in Turkey. It also offers bulb, biological, and serum products, as well as medical devices. The company was founded in 2010 and is headquartered in Ankara, Turkey.

Turk Ilac ve Serum Sanayi AS - Asset Resilience Ratio

Latest as of December 2022: 0.00%

Turk Ilac ve Serum Sanayi AS (TRILC) has an Asset Resilience Ratio of 0.00% as of December 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
TL19.65K
Cash + Short-term Investments
Total Assets
TL1.04 Billion
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2022–2022)

This chart shows how Turk Ilac ve Serum Sanayi AS's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Turk Ilac ve Serum Sanayi AS's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents TL0.00 0%
Short-term Investments TL19.65K 0.0%
Total Liquid Assets TL19.65K 0.00%

Asset Resilience Insights

  • Limited Liquidity: Turk Ilac ve Serum Sanayi AS maintains only 0.00% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Turk Ilac ve Serum Sanayi AS Industry Peers by Asset Resilience Ratio

Compare Turk Ilac ve Serum Sanayi AS's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
Drug Manufacturers - Specialty & Generic -0.02%
Kamada
NASDAQ:KMDA
Drug Manufacturers - Specialty & Generic 21.63%
Dongwha Pharm.Co.Ltd
KO:000020
Drug Manufacturers - Specialty & Generic 1.92%
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
Drug Manufacturers - Specialty & Generic 0.46%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
Drug Manufacturers - Specialty & Generic 1.81%
Kotra Industries Bhd
KLSE:0002
Drug Manufacturers - Specialty & Generic 9.82%
Yuyu Pharma Inc
KO:000227
Drug Manufacturers - Specialty & Generic 1.74%

Annual Asset Resilience Ratio for Turk Ilac ve Serum Sanayi AS (2022–2022)

The table below shows the annual Asset Resilience Ratio data for Turk Ilac ve Serum Sanayi AS.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2022-12-31 0.00% TL19.65K TL1.04 Billion --
pp = percentage points